CXCR4 and dry eye syndrome: The study team created modular nanosystemic polymers with CXCR4-inhibitory moieties to encapsulate anti-miR-155 and limit HSC-KC interaction by blocking CXCR4 signaling in active HSCs and decreasing miR-155 expression in KCs.